Nelipepimut-S

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T33626-100mg	100 mg		-		7 - 10 business days*		-
TGM-T33626-500mg	500 mg		-		7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Nelipepimut-S, as an immunogenic peptide from the HER2 protein, is highly expressed... more

Close menu

Product information "Nelipepimut-S"

Description: Nelipepimut-S, as an immunogenic peptide from the HER2 protein, is highly expressed in breast cancer. Smiles: [C@H](CC1=CC=CC=C1)(C(N[C@@H](CC(C)C)C(O)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CC2=CC=CC=C2)NC([C@@H](NC([C@H](CCCCN)N)=O)[C@H](CC)C)=O)=O)=O)CO)=O)CC(C)C)=O)C)=O. References: Schneble EJ, Berry JS, Trappey FA, Clifton GT, Ponniah S, Mittendorf E, Peoples GE. The HER2 peptide nelipepimut-S (E75) vaccine (NeuVaxTM) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response. Immunotherapy. 2014,6(5):519-31. doi: 10.2217/imt.14.22. Review. PubMed PMID: 24896623.

Keywords:	NeuVax vaccine, E75 peptide, NeuVax
Supplier:	TargetMol
Supplier-Nr:	T33626

Properties

Application:	Targets receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] (ERBB2, HER2, CD340)
Conjugate:	No
MW:	995.21 D
Formula:	C50H78N10O11

Database Information

CAS :	160212-35-1\| Matching products
KEGG ID :	K05083 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Nelipepimut-S"

Write a review